moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KOD Kodiak Sciences > Company Executives
KOD Kodiak Sciences
Post Mkt Price
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Victor Perlroth, M.D.Chief Executive Officer, President and Chairman of the Board113.37M----49male04/28/2022
Dr. Jason Ehrlich, M.D.,PhDChief Medical Officer and Chief Development Officer27.95M----46male04/28/2022
Mr. John A. BorgesonSenior Vice President, Chief Financial Officer, Secretary and Principal Accounting Officer27.87M----60male04/28/2022
Mr. Robert A. ProfusekLead Independent Director471.07K----72male04/28/2022
Dr. Taiyin YangIndependent Director440.32K----68female04/28/2022
Dr. Felix J. Baker,PhDIndependent Director389.82K----53male04/28/2022
Dr. Richard S. Levy,M.D.Independent Director436.07K----64male04/28/2022
Mr. Charles A. BancroftIndependent Director460.97K----62male04/28/2022
Dr. Bassil I. Dahiyat, PhD.Independent Director442.18K----51male04/28/2022
Company Overview More
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
CEO: Dr. Victor Perlroth, M.D.
Market: NASDAQ
Listing Date: 10/04/2018
Hot List
SymbolLatest price%Chg